• The Maximum Hair Results are in: Women Want Men With Hair!

    As if we didn’t already know this, apparently women searching for love on the net are five times more likely to go for the guys with good hair than for those who are losing it, a recent study revealed.

    The UK company Maximum Hair, not currently recommended by the AHLA, conducted an interesting social experiment that helps to solidify the notion that hair does matter to women looking for Mr. Right, or “Mr. Right now.” 

    The two month experiment entailed posting two profiles on various well known internet dating sites. The pictures were identical images of the same man,  except one image was photoshopped to make the guy appear to have a receding hairline.

    Both profiles were identical as well, stating that this 30 year old male was a professional living in London with interests in music, travel and athletics.

    The profile with the full head of hair pulled 108 responses while the balding twin profile received 22 responses. One thing that wasn’t noted in the experiment was the attractiveness level of the women who responded to either profile. Read more ›

     
  • HairDX Hair Loss Test Now Sold In Japan

    It’s been just about a year since we first reported on HairDX, the breakthrough DNA test that looks for a genetic variant found in most bald men. HairDX has certainly helped American hair loss sufferers make better, more informed choices when considering treating their hair loss. As of this month, Japanese men and women will be able to test for their genetic predisposition for hair loss as well.

    PharmaGenoma, Inc., is the first company ever to introduce a test of this kind. The company announced its exclusive agreement with Aderans Company Limited of Tokyo. This breakthrough test will be available March 1, 2009 in Japan and sold as a HairDX test collection kit. The kit is listed with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) as a Class 1 medical device.

    The simple and accurate genetic test provides clear information that is easy to understand. HairDX analyzes the likelihood of a man or woman developing Androgenetic Alopecia, the most common type of hair loss.

     “Aderans partnership with HairDX will allow people in Japan to learn their risk for hair loss early, so they can choose the best treatment to preserve their hair,” says Katsuji Tokumaru, President of Aderans Co. Ltd. Read more ›

     
  • Hair Loss Pill Fights Cancer

    Looks like Finasteride, sold as Propecia to combat male pattern hair loss, has been clinically proven to help prevent prostate cancer but there are still questions left to be answered about the drug. 

    This is the first medication that has demonstrated the ability to help prevent prostate disease, experts said. The American Cancer Society notes that more than 186,000 men are diagnosed with prostate cancer each year. Nearly 29,000 die of it. That is why such special attention is being paid to Finasteride.

    While previous studies show that Finasteride reduces the overall likelihood of getting prostate cancer by 25%, some doctors are concerned that Finasteride may increase the risk of developing the deadliest types of tumors. However, the most recent analyses have nearly dismissed these worries. According to the American Society of Clinical Oncology and the American Urological Association, the drug’s benefits are a good enough reason for men to discuss Finasteride with their doctors. Read more ›

     
 
 

Subscribe

Enter your email address:

 
 

"Spencer Kobren's nationally syndicated show "The Bald Truth" has a dedicated listenership that would have Rush Limbaugh pulling his hair out in envy." --Pittsburgh Tribune-Review.

 
 
 
 
 

BaldTruthTalk Forums

 
 

Talk

 
 
 
 
 
 

News